Milan, Italy

Daniel Ruggieri


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1989-1990

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Daniel Ruggieri in Milan, Italy

Introduction: Daniel Ruggieri is a notable inventor based in Milan, Italy, recognized for his contributions in the field of medicinal chemistry. With an impressive portfolio of patents, Ruggieri has made significant advancements in the development of antihypertensive agents.

Latest Patents: Ruggieri holds two patents, both of which focus on innovative compounds that serve as antihypertensive agents. His most recent patents include "Nor-cholanic acid derivatives, a process for their preparation" and "Aminoglycoside steroids, a process for their preparation." These patents describe various compounds, detailing their structural components and their potential pharmaceutical applications. The patents elucidate that these compounds, including their pharmaceutically acceptable salts, are valuable in treating hypertension, showcasing Ruggieri's commitment to improving health outcomes through scientific innovation.

Career Highlights: Currently, Ruggieri is associated with Farmitalia Carlo Erba S.p.a., where he continues to push the boundaries of pharmaceutical research. His work is characterized by a focus on developing effective, novel compounds that target critical health issues.

Collaborations: Throughout his career, Ruggieri has collaborated with esteemed colleagues, including Laura Chiodini and Mauro Gobbini. These partnerships have undoubtedly enhanced his research efforts, allowing for a diverse exchange of ideas and expertise within the field.

Conclusion: Daniel Ruggieri stands out as an innovative mind in the realm of medicinal chemistry. His patents reflect a dedication to advancing healthcare solutions, particularly for hypertension. As he continues his work with Farmitalia Carlo Erba S.p.a., Ruggieri's contributions will likely have a lasting impact on the pharmaceutical industry and patient well-being.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…